Selected by a Distinguished Jury of Global Biopharma Leaders for Dren Bio’s Outstanding Innovation, Impact, and Scientific Excellence – SAN CARLOS, ...
NEOK Bio, Inc., a biotechnology company focused on the development of novel antibody drug conjugates (ADCs) for improving ...
The startup claims its medicines may be able to overcome the limitations of conventional antibody-drug conjugates by ...
Totipotent Cells: Often regarded as the "holy grail" of stem cell biology, these cells can develop into any type of cell in the body, offering vast possibilities for tissue regeneration.
This acceptance marks the fifth major medical conference this year to feature bexmarilimab in an oral session, reinforcing the drug's unique mechanism in hematologic malignancies and potential to ...
Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
News-Medical.Net on MSN
Hidden cell structures reveal a common weakness in leukemia
A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like ...
The Global Tube Packaging Market Size is projected to grow at a CAGR of 6.82% from 2026 to 2032, according to a new report ...
Study reshapes view of how a common leukemia begins and could point to new therapeutic strategies targeting a common weakness.
Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today is providing a number of strategic updates, including its recently executed option agreement with Incyte ...
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Jeremy Sokolove, M.D., as Chief Medical Officer. Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback